Multisample technique to analyze cell adhesion

July 06, 2020

An efficient, robust method of examining the interactions between cells uses fluorescent tagging to simultaneously analyze multiple cell populations, speeding up a once tedious and limiting process. The new assay developed by KAUST also has applications in studying cellular processes in inflammation or cancer cell metastasis and in assessing potential treatments.

Cells move through blood vessels via cell adhesion--the interaction and attachment of cells to one another via specialized molecules on cell surfaces. During blood flow, shear forces act on the cells to help orchestrate cell adhesion. Manipulation of cell adhesion can lead to inflammation and diseases, like cancer, while pathogens, such as viruses exploit cell adhesion to infect the body.

"The conventional assay used to study cell-cell interactions is the parallel plate flow chamber (PPFC) assay, which records videos of cells rolling in flow and adhering to molecules on endothelial cells (blood vessel lining cells)," says group leader Jasmeen Merzaban. "This assay has been used for decades, but it is prone to error and possible bias, and it can only analyze one cell type at a time, making it hugely time consuming."

Ayman AbuElela, with the other graduate students in Merzaban's lab, wanted to improve upon PPFC and speed up analyses.

Their new fluorescent multiplex cell rolling assay (FMCR) uses unique fluorescent tags to label up to seven cell population types. The cell samples are mixed just prior to entering the simulated flow over a layer of endothelial cells. A spectral confocal microscope captures images of the mixed cell populations in real time, at high temporal resolution, in a single pass. This allows researchers to collect data on cell kinetics, including the rolling frequency, velocity and tethering capability of individual cell types.

"We developed a comprehensive data analysis pipeline, which enables us to analyze the multiple cell types we obtain by this approach and achieves high statistical power and sensitivity," says AbuElela. "FMCR is now used in our lab to study the migration of various human cells including stem cells, activated immune cells and breast cancer cells."

Another advantage of the new procedure is that before or during the assay, a test compound, such as a new drug, can be added to the cells to investigate the effect of the compound on cell adhesion.

"Such studies provide major insights into the effect of treatments on the migration and metastasis of cells and on how the drugs might work inside the body," notes Merzaban.
-end-


King Abdullah University of Science & Technology (KAUST)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.